SANA
HEALTHCARESana Biotechnology Inc
$3.64+0.15 (+4.30%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving SANA Today?
No stock-specific AI insight has been generated for SANA yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$1.60$6.55
$3.64
Fundamentals
Market Cap$983M
P/E Ratio—
EPS$-0.96
Dividend Yield—
Dividend / Share—
ROE-1.2%
Profit Margin—
Debt / Equity—
Trading
Volume3.6M
Avg Volume (10D)—
Shares Outstanding270.0M
SANA News
21 articles- Sana Biotechnology to Present at the BofA Securities 2026 Healthcare ConferenceYahoo Finance·May 5, 2026
- Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual MeetingYahoo Finance·Apr 27, 2026
- Sana Biotech (SANA), Mayo Clinic Partner to Advance Cell Therapy for Type 1 DiabetesYahoo Finance·Apr 27, 2026
- Assessing Sana Biotechnology (SANA) Valuation After Mayo Clinic Partnership And Equity InvestmentYahoo Finance·Apr 23, 2026
- Wedbush Lifts PT on Sana Biotechnology (SANA) to $7 From $6Yahoo Finance·Apr 20, 2026
- Kailera Therapeutics Debut Marks Largest Biotech IPO Since 2021 Amid Weight Loss RaceBenzinga·Apr 17, 2026
- Kailera nets $625M in one of biotech’s biggest-ever IPOsBiopharmadive·Apr 16, 2026
- Sana Biotechnology Inc. (SANA) Hits New Milestone on Cell Therapy for Type 1 DiabetesYahoo Finance·Apr 14, 2026
- Sana Biotechnology and Mayo Clinic Announce Strategic Collaboration Focused on Improving Care in Type 1 Diabetes and Accelerating Development of SC451Yahoo Finance·Apr 13, 2026
- Sarepta tests new Elevidys safeguards; Sana advances diabetes cell therapyBiopharmadive·Mar 16, 2026
- Sector Update: Health Care Stocks Mixed Late AfternoonYahoo Finance·Mar 13, 2026
- Sector Update: Health Care Stocks Advance Friday AfternoonYahoo Finance·Mar 13, 2026
- Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without ImmunosuppressionYahoo Finance·Mar 13, 2026
- Sana: Q4 Earnings SnapshotYahoo Finance·Mar 3, 2026
- Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business UpdatesYahoo Finance·Mar 3, 2026
- Sana Biotechnology, Inc. (SANA): A Bull Case TheoryYahoo Finance·Feb 28, 2026
- Sana Biotechnology (SANA) Appoints Industry Veteran Brian Piper as New CFOYahoo Finance·Feb 26, 2026
- Assessing Sana Biotechnology (SANA) Valuation After The Appointment Of A New CFOYahoo Finance·Feb 26, 2026
- Sana Biotechnology to Present at March 2026 Investor ConferencesYahoo Finance·Feb 23, 2026
- Genomics Stocks That Deserve a Place in Your Portfolio in 2026Yahoo Finance·Feb 20, 2026
- Sana Biotechnology Appoints Brian Piper as Executive Vice President, Chief Financial OfficerYahoo Finance·Feb 17, 2026
All 21 articles loaded
Price Data
Open$3.31
Previous Close$3.49
Day High$3.32
Day Low$3.18
52 Week High$6.55
52 Week Low$1.60
52-Week Range
$1.60$6.55
$3.64
Fundamentals
Market Cap$983M
P/E Ratio—
EPS$-0.96
Dividend Yield—
Dividend / Share—
ROE-1.2%
Profit Margin—
Debt / Equity—
Trading
Volume3.6M
Avg Volume (10D)—
Shares Outstanding270.0M
About Sana Biotechnology Inc
Sana Biotechnology, Inc., a biotechnology company, focuses on the use of modified cells as medicines. The company is headquartered in Seattle, Washington.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—